Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-08-25
1999-12-07
Mach, D. Margaret
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514443, 549 23, 549 49, 549 58, A01N 4318, A01N 4312, C07D33504, C07D33552
Patent
active
059984651
ABSTRACT:
Compounds having anti-inflammatory and anti-oxidant activity are disclosed. The compounds are useful in preventing and treating inflammatory disorders through several mechanisms. Methods of treatment employing these properties of the compounds and corresponding pharmaceutical compositions are disclosed.
REFERENCES:
patent: 4523024 (1985-06-01), Shiono et al.
patent: 4550022 (1985-10-01), Garabedian et al.
patent: 4681890 (1987-07-01), Kanehira et al.
patent: 4857516 (1989-08-01), Terao et al.
patent: 4975419 (1990-12-01), Newton et al.
patent: 4988728 (1991-01-01), Gerson et al.
patent: 5084575 (1992-01-01), Kreft, III et al.
patent: 5424321 (1995-06-01), Hellberg et al.
patent: 5750564 (1998-05-01), Hellberg et al.
Bazan, H.; "Response of Inflammatory Lipid Mediators following Corneal Injury"; Lipid Mediators in Eye Inflammation New Trends Lipid Mediator Res. Basel; Karger vol. 5; pp. 1-11 (1990).
Bellavite, P.; "The Superoxide-Forming Enzymatic System of Phagocytes"; Free Radical Biology & Medicine; 4; pp. 255-261 (1988).
Bonne, et al.; "2-(2-Hydroxy-4-methylphenyl)aminothiazole Hydrochloride as a Dual Inhibitor of Cyclooxygenase/Lipoxygenzse and a Free Radical Scavenger"; Drug Research 39 II, No. 10; pp. 1242-1245 (1989).
Campbell, W.; "Lipid-Derived Autacoids"; Goodman and Gilman's The Pharmacological Basis of Therapeutics, Pergman Press, New York; pp. 600-617 (1990).
Chow, C.; "Vitamin E and Oxidative Stress"; Free Radical Biology & Medicine; vol. 11; pp. 215-232 (1991).
Cohen, et al.; "Lewis Acid Mediated Nucleophilic Substitution Reactions"; Journal of Organic Chemistry; vol. 54; pp. 3282-3292 (1989).
Derwent Publications Ltd., London, GB; AN 83-55213k, "Indomethacin alpha-tocopherol ester preparation--by reacting indomethacin and alpha-tocopherol in and inert solvent" (JP 58072579 abstract), 1983.
Derwent Publications Ltd., AN 84-007991, 1984.
Derwent Publications Ltd., AN 85-027830, 1985.
Derwent Publications Ltd., AN 87-246978, 1987.
Derwent Publications Ltd., AN 930297401, 1993.
Duchstein and Gurka; "Activated Species of Oxygen: A challenge to Modern Pharmaceutical Chemistry"; Archives of Pharmacology; vol. 325; pp. 129-146 (1992).
Duniec, et al.; "Antioxidant properties of some chemicals vs their influence on cyclooxygenase and lipoxidase activities"; Biochemical Pharmacology; vol. 32; No. 14; pp. 2283-2286 (1983).
Gifford, H.; "The Treatment of Sympathetic Ophthalmia"; Ophthalmoscope; vol. 8; pp. 257-259 (1910).
Goa and Chrisp; "Ocular Diclofenac"; Drugs & Aging; vol. 2; No. 6; pp. 473-486 (1992).
Graff and Anderson; "1-[4-[3[[BIS(4-Flurorphenyl) hydroxymethyl]-1-peperidinyl]propoxy]-3-methoxyphenyl]ethanone (AHR-5333): A Selective Human Blood Neutrophil 5-Lipoxygenase Inhibitor"; Prostaglandins; vol. 38; No. 4; pp. 473-497 (1989).
Hammond et al. "Antioxidant-based inhibitors of leukotriene biosynthesis. The discovery of 6-[1-[2-(hydroxymethyl)phenyl]-1-propen-3-yl]-2,3-dihydro-5-benzofuranol, a potent topical antiinflammatory agent", Journal of Medicinal Chemistry, vol. 33, No. 3, pp. 908-918 (1990).
Insel, P.; "Analgesic-Antipyretics and Antiinflammatory Agents"; Goodman and Gilman's The Pharmacological Basis of Therpeutics; Pergman Press, New York; pp. 638-669, 681 (1990).
Lamba, et al.; "Spectroscopic detection of lipid peroxidation products and structural changes in a sphingomyelin model system"; Biochimica et Biophysica Acta; vol. 1081; pp. 181-187 (1991).
Nelson, P.; "Cyclooxygenase Inhibitors"; CRC Handbook of Eicosanoids: Prostaglandins, and Related Lipids, vol. II Drugs Acting Via the Eicosanoids; CRC Press, Boca Raton, FL; pp. 59-133 (1989).
Petty, et al.; "Protective effects of an .alpha.-tocopherol analogue against myocardial reperfusion injury in rats"; European Journal of Pharmacology; vol. 210; pp. 85-90 (1992).
Sies and Murphy, "Role of tocopherols in the protection of biological systems against oxidative damage"; Journal of Photochemistry and Photobiology; vol. 8; pp. 211-218 (1991).
Skoog and Beck; "Studies on the Fibrinogen, Dextran and Phytohemagglutinin Methods of Isolating Leukocytes"; Blood; vol. 11; pp. 436-454 (1956).
Vane, J.; "Inflammation and the mechanism of action of anti-inflammatory drugs"; FASEB Journal; vol. 1, pp. 89-96 (1987).
Delgado Pete
Hellberg Mark
Nixon Jon C.
Alcon Laboratories Inc.
Mach D. Margaret
Mayo Michael C.
LandOfFree
Esters of non-steroidal anti-flammatory carboxylic acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Esters of non-steroidal anti-flammatory carboxylic acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Esters of non-steroidal anti-flammatory carboxylic acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-824493